Revenue
2024
2025
Clearmind Medicine Inc. (CMND)
Price$1.16Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — |
| Research & development | $2.1M | $1.4M | $1.5M | $3.1M | $473,652 | — |
| Operating expenses | $5.7M | $5.7M | $6.3M | $6.3M | $2.7M | — |
| Operating income | −$5.7M | −$5.7M | — | −$6.3M | — | — |
| EBITDA | −$3.7M | −$4.8M | −$8.5M | −$6.8M | — | — |
| Net income | −$3.9M | −$5.3M | −$8.6M | −$6.9M | −$2.7M | — |
| Basic EPSper basic share | -$30.35 | -$67.80 | -$1,703.04 | -$159.11 | -$88.16 | — |
| Diluted EPSper diluted share | -$30.35 | -$67.80 | -$1,703.04 | -$159.11 | -$88.16 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
HRT FINANCIAL LP | 35.14K |
CITADEL ADVISORS LLC | 11.71K |
AdvisorShares Investments LLC | 1.17K |
MORGAN STANLEY | 700 |
ROYAL BANK OF CANADA | 287 |
Caitong International Asset Management Co., Ltd | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | SellClass A Shares | 22.1K | $3.31 | $73.3K | 81.4K |
| Jun 15, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | SellCommon Stock | 3.2K | $3.32 | $10.6K | 103.5K |
| Jun 12, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | SellCommon Stock | 2.1K | $3.36 | $7.1K | 106.7K |
| Jun 11, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | SellCommon Stock | 225.2K | $0.12 | $27.0K | 1.84M |
| Jun 10, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | BuyCommon Stock | 2.16M | $0.15 | $323.9K | 2.06M |